chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had acute illnesses and chronic and long standing health conditions.     On 31-Mar-2022 at 12:26 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Mar-2022 at 12:26 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 31-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  This vaccine was administered up until its Mfg Exp date of 04-Apr-2022. The patient received the booster dose.  No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
Low grade fever, sensitive skin, body aches, fatigue, body aches. Headaches
Woke up with temperature of 103 around 2 AM. Within 30-45 minutes my temperature climbed up to its highest  of 107.1. Relieved within 15 minutes of notice with ice packs and ibuprofen. Lessened fever ranged from 102-104 for 30-60 minutes.  Migraine like headache afterwards for 14 hours. Body aches and drowsiness lasted for 2 days.
Injection site was hot; Injection site was itchy; Injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site was hot), VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was hot), VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red). At the time of the report, VACCINATION SITE WARMTH (Injection site was hot), VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient reported that their injection site was itchy, red, and hot. The patient did not confirm whether they received Moderna COVID19 vaccine.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-071301 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071301:crosslinked
arm is sore and irritated; arm is sore and irritated; lump at the injection site on his right arm; Soreness that radiates from his right shoulder to his neck; Soreness that radiates from his right shoulder to his neck; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: unknown) (age at the time of vaccination 40 years) via unspecified route of administration, administered in arm right in 12May2021 around 17:30-18:00 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history was none. Concomitant medications were not reported. Patient's medical history (including any illness at time of vaccination) was none. Family medical history relevant to AE was none. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional vaccines administered on same date of the Pfizer suspect was none. Caller reports that a magnet and or a quarter sticks to their body at their vaccine injection site on 16May2021. He reports that this was something that multiple people are experiencing as there are reports on social media about this. Caller asking what was in the vaccine that makes metal or magnets stick to them. Caller also reports having a lump at the injection site on his right arm as well as soreness that radiates from his right shoulder to his neck on 12May2021. Caller states the first shot was a week ago, and his arm was sore and irritated on an unspecified date. Caller states that he had seen things posted on social media. Caller states he wonders why quarters and magnets will stick the injection site. Stated he knows that was not normal. Stated they say they used needles that have been magnetized, but he has had a lot of shots in his life and this was not normal. Caller states yes, this was a safety concern, it was not normal. The patient did not receive any treatment for the events and stated he takes his normal medication but nothing for the events. AE(s) does not require a visit to emergency room/physician office. Prior Vaccinations (within 4 weeks) was none. AE(s) following prior vaccinations was none. The outcome of the events lump at the injection site on his right arm, soreness that radiates from his right shoulder to his neck was not recovered and unknown for other events.   Follow-up attempts are completed. No further information was expected.
Information has been received from a Licensed Practical Nurse concerning a 9 year old female patient with no pertinent medical history and no drug reactions or allergies who on 10-AUG-2010 was vaccinated IM with 0.5 ml of the first dose of GARDASIL (Lot # 666929/0331Z, expiration date not available) and on 09-NOV-2010 received the second dose of the vaccine (lot $ 666507/0768Z, expiration date not available). There was no concomitant medication. The nurse reported that patient fainted immediately after administration of her first and second dose of GARDASIL injection. The patient recovered after each dose while in the office and did not required medical attention. No lab diagnostics studies were performed. Additional information has been requested.
shortness of breath; This case was reported by a consumer via call center representative and described the occurrence of shortness of breath in a 70-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Anoro with an associated reaction of dyspnoea (using since March 26, 2020 and was still having trouble breathing, defined as shortness of breath, refer case US2020AMR064641) and albuterol  with an associated reaction of dyspnoea (albuterol an unknown manufacturer's, refer case US2020AMR064641).   In November 2017, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced shortness of breath. On an unknown date, the outcome of the shortness of breath was unknown.   It was unknown if the reporter considered the shortness of breath to be related to Boostrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient also mentioned that she had a shot of Boostrix in November 2017 and experienced shortness of breath. Did not consent to follow-up. The patient was having a hard time breathing during this call.
If someone had the Moderna vaccine first dose Feb 2020 but didn't get the 2nd do they need to restart the series; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (If someone had the Moderna vaccine first dose Feb 2020 but didn't get the 2nd do they need to restart the series) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (If someone had the Moderna vaccine first dose Feb 2020 but didn't get the 2nd do they need to restart the series). At the time of the report, PRODUCT DOSE OMISSION ISSUE (If someone had the Moderna vaccine first dose Feb 2020 but didn't get the 2nd do they need to restart the series) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.
Pain and numbness to the right deltoid. Pain is a burning sensation that radiates down to the right wrist and has a shooting sensation of pins and needles, when I  move my arm forwards, backwards, flex and raise above elbow length.  The center of my right deltoid has  constant tingling sensation.  The pain has become so intolerable that I am unable to perform my daily activities without the constant use of Ibuprofen and Tylenol, that only dulls my pain and my children are now having to assist me with dressing, grooming, and bathing. The pain has increased from 6/10 to 10/10 with certain movements, and the medications are upsetting my stomach.
missed his second dose scheduled; he tested positive on 04Aug2021; he tested positive on 04Aug2021; This is a spontaneous report contactable consumer (patient) from a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number, Expiry date was not reported), via an unspecified route of administration on 13Jul2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced he tested positive on 04aug2021, missed his second dose on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test was positive on 04Aug2021 he tested positive on 04Aug2021. Medical Information was yes. Customer and/or medical inquiry forwarded or referred to MI. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Approximately 4 days after injection, severe pain developed in my back and abdomen on the right side. On the 5th day of pain a rash developed in a straight line starting just above and to the right of my belly button (approx two inches long). The next day more bumps appeared making the line of rash approx 3 inches long and bumps also appeared on my back, on the right side. On 4/6 (Tuesday) CNP confirmed that is was shingles.
It started with a neck ache, then chills ,muscle aches , headache, bone pain to my forearms and fever.  101.8 after Motrin, this morning 100.5.
Arm sore within 5 hours,  Headache within 10 hours that lasted for about 14 hours
Stiff arm (almost immediately and still ongoing)  **After about 10 hours the following developed** Extreme Lethargy (lasting 3 days) Migraine (lasting 2 days) Vomiting - Could not even consume liquids (24 hours) Loss of appetite (ongoing) Fever (24 hours) Chills (48 hours) Uncontrollable body shakes (48 hours) diarrhea (24 hours) dizziness (ongoing)
Anaphylaxis, confirmed by ER; This is a spontaneous report from a contactable other healthcare professional (HCP). A 55-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6200, expiration date was unknown), intramuscularly, administered in the left arm on 19Feb2021 at 12:15 PM as a single dose for COVID-19 immunization. The vaccination facility type was reported as the hospital. The patient's medical history and concomitant medications were not reported. The patient previously took codeine and hydrocodone bitartrate, paracetamol (VICODIN), from which she had known allergies. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination. She was not tested for COVID post vaccination. On 19Feb2021 at 12:15 PM, the patient experienced anaphylaxis, confirmed by emergency room (ER). The adverse event (AE) resulted in a doctor or other HCP office/clinic visit and emergency room/department or urgent care visit. Therapeutic measures were taken as a result of anaphylaxis, confirmed by ER, which included epinephrine, steroids, and antihistamines. The patient recovered from the event on an unspecified date.; Sender's Comments: Based on known drug safety profile and temporal association, the causal relationship between bnt162b2 and the event anaphylactic reaction cannot be excluded.
Moderna on 2/25 and 3/26. Positive on 8/22 admited 8/27 to current
Chills and extreme aches up and down the spine as well as the muscles from neck down through the legs.  I have had continuing bouts with chills and difficulty recovering from muscle pain as well as difficulty with walking.
I had very severe pain in left arms, also on the left side of body from waist to feet, very sharp pain on that part of the body, felt it on the spine. Also sharp pain on chest on the right side which cause short of breath. That is why I refuse to take the second shot of vaccine. I am scared of the chest pain.
Swollen injection site; Sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Sore injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Sore injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Sore injection site) outcome was unknown.            Concomitant product use was not provided by the reporter.
I had a DVT in my left leg in the vein confirmed by ultrasound. I started with a pain in my leg and went to be seen and they found a blood cot. They placed me on Zorolto for 3 months and to follow up with Hematology.
Benign paroxysmal positional vertigo (BPPV); Dizziness; Elevated blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: NDC:59267-1000-01) via an unspecified route of administration in the left arm on 05Mar2021 at 13:00 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) 2.5 mg, atorvastatin (MANUFACTURER UNKNOWN) 10 mg and olopatadine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 05Mar2021 at 20:00, the patient experienced benign paroxysmal positional vertigo (BPPV), dizziness only when lying down and also elevated blood pressure. It was reported that, there was no other side effects at the time of reporting. On 05Mar2021 at 20:00, the patient underwent blood pressure test and the result was elevated blood pressure of 158/85 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events benign paroxysmal positional vertigo (BPPV), dizziness and elevated blood pressure was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Received shot on 8/24/21.  Started having headache, pressure/slight swelling of forehead and swelling feeling/cool type sensation around the eyes around 7pm that evening.  Headache continued into following day only.  Swelling feeling of forehead continued into the following day only.  Swelling feeling/cool type sensation around the eyes has continued since then and I am still having that feeling today 9/8/21.  Lightheaded on 8/25/21 only lasted 1 day.  Slight soreness of arm lasted for approximately 1 day only.  No medications were taken after the shot to treat any of the symptoms.
29MAR93 pt stating h/a & red face began 1 hr p/vax; seen ASAP; devel difficulty swallowing & talking; also rash, itching, n,v,d; face peeling;
Woke from nap warm and irritable.  Running low grade fever.  By 7 PM temp was up to 101.  Administered Tylenol 5 mg and within minutes became lethargic, confused, limp.  Temp lowered to low grade.  2 am checked on him.  Very rapid heart beat, awake running temp 102.  Administered Advil 1 tsp and took to Emergency. Better on way to hospital.  Follow-up with doc in morning where he was spiking a fever again. Administered Advil to bring down.
Hives; This case was reported by a other health professional via call center representative and described the occurrence of hives in a 6-year-old male patient who received DTPa-IPV (Kinrix) (batch number HB7L7, expiry date 31st August 2021) for prophylaxis.   On 24th January 2020, the patient received Kinrix. In January 2020, less than a week after receiving Kinrix, the patient experienced hives. On an unknown date, the outcome of the hives was unknown.   It was unknown if the reporter considered the hives to be related to Kinrix.  Additional details were reported as follows: The patient experienced hives after receiving Kinrix vaccine. The reporter wanted to know whether patient could receive Boostrix vaccine in future. The reporter consented to follow up.
Chronic fatigue even though it has been 3 weeks since the vaccination . It was my 2nd dose.
Severe arm pain in left deltoid and shoulder (same arm as injection). Pain started 12 hours after receiving the injection and lasted about 24 hours. I took Advil and applied a cold compress throughout the day which greatly reduced the pain. I no longer needed a pain reliever after 24 hours.
Almost immediately after shot, patient got light headed/dizzy. Then started to seize for less than a minute. EMTs called. Took BP 107/85. Patient was then nauseous. EMTs tested blood sugar, HR and BP. Did not have to transport. Will see dr Monday.
Swelling in hands Muscle pain/cramping Tingling (pins and needles) on skin  Progressing up arm to neck down back and into legs  Still experiencing
The patient received 3 Vaccines total. Pentacel in the right thigh, Fluarix in left thigh- upper, and PCV13 in left thigh- lower. After the child had been vaccinated a seizure occurred and mom took the child to the hospital.
This case was reported by a physician and described the occurrence of inconsolable crying in a 2-month-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent vaccination included haemophilus influenzae type b vaccine (non-gsk); non-GSK manufacturer; unknown; unknown given on 26 April 2012; PREVNAR (non-gsk); non-GSK manufacturer; unknown; unknown given on 26 April 2012; ROTATEQ (non-gsk); non-GSK manufacturer; unknown given on 26 April 2012. There were no concurrent medications. On 26 April 2012 the subject received 1st dose of PEDIARIX (.5 ml, unknown, right thigh). On 26 April 2012, 4 hours after vaccination with PEDIARIX, the subject experienced inconsolable crying, fussy and inconsolable. The 2-month old subject received PEDIARIX during a well child examination. Four hours later the mother called and stated the subject was very fussy and could not be consoled. The subject was treated with TYLENOL and MOTRIN without any effect. Approximately six hours later on 26 April 2012, the events were resolved. Follow-up information was received on 24 August 2012 via physician who reported discrepant onset date of 27 June 2012 and outcome date of 28 June 2012; previously reported as 26 April 2012 and 26 April 2012. The outcome of the events were resolved. The reporting physician considered the events probably related to vaccination with PEDIARIX.
Migraine; Stiff neck; Brain zaps on the back right side of head; Pain in injection arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PAA165969) via an unspecified route of administration in the right arm on 14Sep2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included heart palpitations, high cholesterol, thrombophilia, and allergy to paper tape. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 15Sep2021 at 01:00, the patient experienced migraine, stiff neck, pain in injection arm, and the patient had been experiencing brain zaps on the back right side of the head, especially when the patient started to drift off to sleep, it jolted the patient back awake. It felt like an electrical zap inside the patient's brain shocking him every about 5 to 10 minutes. It had subsided but still had it once or twice every hour. The patient's headache also did not go away with medicine (unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department, or urgent care. Therapeutic measures were not taken as a result of the events migraine, stiff neck, pain in injection arm, and brain zaps on the back right side of head. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, stiff neck, pain in injection arm, headache, and brain zaps on the back right side of head was not recovered at the time of this report.
31DEC seen by MD dx bronchitis given meds; 15JAN92 to ER t103 R secondary to vax, macular papular rash, quivering-shaking, blue lips;
Light headed, nauseated not feeling right. Arm pain moved from muscle to the joint now also. Tired.